|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD
735.27 million
|
|
CAGR
(2023-2028)
|
4.81%
|
|
Fastest
Growing Segment
|
Molecular
Diagnostic Tests
|
|
Largest
Market
|
Europe
|
Market Overview
Global Bovine Tuberculosis Diagnosis Market has
valued at USD 735.27 million in 2022 and is anticipated to project impressive
growth in the forecast period with a CAGR of 4.81% through 2028. The Global
Bovine Tuberculosis Diagnosis Market is a dynamic and evolving sector dedicated
to the detection and management of bovine tuberculosis (bTB) in cattle
populations. Bovine tuberculosis is a contagious disease caused by
Mycobacterium bovis, which not only poses a significant threat to animal health
but also carries potential zoonotic implications.
Key Market Drivers
Rising Awareness and Concern for Animal Health
In recent years, there has been a remarkable
increase in awareness and concern for animal health, particularly in the
livestock industry. This heightened awareness has had a profound impact on
various aspects of animal agriculture, including disease management. One
disease that has come under the spotlight due to its implications for both
animal health and public health is bovine tuberculosis (bTB).
Livestock, including cattle, play a crucial role in
global agriculture. They are a source of food, income, and livelihood for
millions of people. Any disease outbreak in livestock can have severe economic
consequences, including reduced productivity, increased veterinary costs, and
trade restrictions. As a result, cattle owners and the livestock industry at
large are becoming increasingly conscious of the economic impact of diseases
like bTB.
There is a growing emphasis on animal welfare, with
consumers and stakeholders demanding better living conditions and healthcare
for animals. Bovine tuberculosis can cause significant suffering to affected
cattle, including weight loss, lethargy, and respiratory distress. This
suffering raises ethical concerns and highlights the importance of early
detection and treatment.
Consumers are increasingly concerned about the
safety and quality of the meat and dairy products they consume. Bovine
tuberculosis can pose a risk to food safety if not detected and managed
properly. Contaminated dairy products can transmit the disease to humans,
making it a public health concern. As a result, consumers are more inclined to
support measures that ensure disease-free cattle herds.
As awareness of the impact of bTB on animal health
and welfare grows, cattle owners and industry stakeholders are more willing to
invest in the diagnosis and management of the disease. They recognize that
early detection is key to preventing the spread of bTB within herds.
The heightened concern for animal health has led to
increased funding for research and development in the field of veterinary
diagnostics. This investment has resulted in the development of more accurate
and efficient diagnostic tools for bTB, including interferon-gamma release
assays (IGRAs), PCR-based tests, and serological tests.
Governments and regulatory bodies are responding to
the rising awareness of animal health concerns by implementing stricter
regulations related to disease monitoring and control. These policies often
mandate regular bTB testing and surveillance, creating a consistent demand for
diagnostic services and products.
Increased awareness has encouraged collaboration
between cattle owners, veterinary professionals, diagnostic laboratories, and
research institutions. This collaboration promotes the exchange of knowledge
and best practices, leading to more effective bTB management strategies.
Zoonotic Risk and Public Health Concerns
Zoonotic diseases, those that can be transmitted
from animals to humans, have been a growing concern in the realm of public
health. Among these diseases, bovine tuberculosis (bTB) stands out as a
significant threat due to its zoonotic potential. The awareness of this
zoonotic risk and associated public health concerns has been a driving force
behind the growth of the Global Bovine Tuberculosis Diagnosis Market.
Bovine tuberculosis is caused by Mycobacterium
bovis, a pathogen that can infect both cattle and humans. While human
infections are relatively rare compared to those in cattle, they can have
severe consequences. Transmission to humans primarily occurs through the
consumption of unpasteurized dairy products or direct contact with infected
cattle. Once infected, humans can develop a range of health issues, including
respiratory problems and even death in severe cases.
The zoonotic risk associated with bTB has raised
significant public health concerns. Governments, health organizations, and the
general public have become increasingly aware of the potential consequences of
this disease. This heightened concern has led to greater efforts to control and
manage bTB in cattle herds.
Zoonotic diseases like bTB require early detection
to prevent transmission to humans. As a result, there is a growing demand for
accurate and timely diagnostic tools to identify infected cattle. This demand
is a key driver of market growth, as it necessitates the availability of
reliable diagnostic tests.
The contamination of dairy products with
Mycobacterium bovis poses a direct threat to food safety. In response, food
safety regulations have become more stringent, requiring rigorous testing of
cattle herds. Compliance with these regulations drives the need for advanced
diagnostic methods, further boosting the market.
In an era of increased global connectivity,
zoonotic diseases can easily cross borders. The risk of bTB spreading across
regions and countries has led to international health security concerns. As a
result, there is a push for standardized and effective diagnostic methods to
ensure the early detection and containment of the disease.
The zoonotic risk of bTB has spurred research and
development efforts aimed at improving diagnostic accuracy and efficiency.
These investments have resulted in the development of more advanced diagnostic
assays, such as interferon-gamma release assays (IGRAs) and PCR-based tests,
which are crucial for early detection.
Advancements in Diagnostic Technologies
Advancements in diagnostic technologies have been a
driving force behind the evolution of healthcare and disease management across
various sectors. In the realm of veterinary medicine, these innovations are
playing a pivotal role in transforming the Global Bovine Tuberculosis Diagnosis
Market. Bovine tuberculosis (bTB), a contagious disease affecting cattle and
posing zoonotic risks, has witnessed significant growth in diagnostic
capabilities thanks to these technological strides.
Accurate and early diagnosis of bovine tuberculosis
is crucial for disease management and control. Traditionally, diagnostic
methods relied on tuberculin skin tests, which had limitations in terms of
sensitivity and specificity. However, recent advancements in diagnostic
technologies have revolutionized the field, offering more reliable and
efficient tools for detecting bTB.
IGRAs are a prime example of technological
advancement in bTB diagnosis. These blood tests measure the release of
interferon-gamma, a protein produced by the immune system when exposed to
Mycobacterium bovis, the causative agent of bTB. IGRAs are highly specific and
sensitive, reducing the likelihood of false positives and negatives. The
adoption of IGRAs has significantly improved the accuracy of bTB diagnosis.
Polymerase Chain Reaction (PCR) technology has
revolutionized molecular diagnostics, including bTB detection. PCR-based tests
can detect the DNA of Mycobacterium bovis in clinical samples, offering a
highly sensitive and specific method for identifying infected cattle. These
tests have greatly expedited the diagnosis process, allowing for earlier
intervention and control measures.
Serological tests detect specific antibodies
produced by the host's immune system in response to bTB infection. Advancements
in serological test development have resulted in improved accuracy and
efficiency. These tests provide a complementary diagnostic approach to existing
methods, enhancing the overall diagnostic toolkit.
The integration of digital health solutions has
streamlined the diagnostic process. Digital platforms and data analytics enable
real-time monitoring of disease prevalence and transmission patterns.
Additionally, they facilitate data sharing and communication among
stakeholders, leading to more effective disease management strategies.
Miniaturized diagnostic devices and point-of-care
tests are becoming increasingly available. These technologies allow for rapid,
on-site testing, reducing the time and resources required for diagnosis. This
is particularly valuable in remote or resource-limited areas where timely bTB
diagnosis is essential.
Automation and robotics have improved the
efficiency and throughput of diagnostic laboratories. High-throughput robotic
systems can process a large number of samples quickly and accurately, enabling
large-scale bTB testing and surveillance efforts.
Increasing Cattle Populations
The Global Bovine Tuberculosis Diagnosis Market is
undergoing a period of significant growth, driven by various factors, one of
which is the increasing global population of cattle. As cattle populations
continue to rise to meet the growing demand for meat and dairy products, the
need for effective disease surveillance and control, particularly in the case
of bovine tuberculosis (bTB), becomes more pronounced.
Cattle are a fundamental component of the global
agricultural landscape, providing essential resources such as meat, milk, and
hides. The rising human population, urbanization, and changing dietary habits
have led to an increased demand for livestock products. Consequently, cattle
populations have been expanding to meet this growing demand. As emerging
economies experience income growth and urbanization, there is a rising demand
for protein-rich diets, including beef and dairy products. This trend has led to
an increase in cattle production worldwide. The dairy industry, in particular,
has seen significant expansion due to increased demand for milk and dairy
products. Dairy cattle populations have surged in response to this demand. In
many regions, cattle farming remains a primary source of livelihood for rural
communities. The growth in cattle populations supports the livelihoods of
millions of smallholder farmers.
With more cattle in existence, the probability of
bTB infections increases. This necessitates more extensive disease surveillance
and diagnostic testing to identify infected animals. Regulatory bodies and
governments, recognizing the potential for bTB transmission, often require
routine testing and surveillance of cattle herds. As cattle populations grow,
so does the demand for diagnostic services and tests. The economic consequences
of bTB in cattle herds can be severe. Reduced productivity, treatment costs,
and trade restrictions can have a significant impact on the livestock industry.
Therefore, cattle owners and industry stakeholders are more willing to invest
in diagnostic solutions to protect their herds and investments. As cattle
populations rise globally, the demand for bovine tuberculosis diagnosis
services extends beyond individual countries. This expansion provides
opportunities for diagnostic companies to broaden their market reach and cater
to the needs of diverse regions.
Download Free Sample Report
Key Market Challenges
Diagnostic Accuracy
One of the primary challenges in bTB diagnosis is
achieving high diagnostic accuracy. Traditional methods like the tuberculin
skin test can yield false-positive or false-negative results, leading to
misdiagnosis. Achieving a balance between sensitivity and specificity in
diagnostic tests is crucial to ensuring accurate and reliable results.
Early Detection
Early detection of bTB is essential to prevent the
disease's spread within cattle herds and minimize its impact on animal health
and productivity. However, achieving early detection is challenging because bTB
can remain latent in cattle for extended periods before becoming detectable.
Zoonotic Risk
Bovine tuberculosis is a zoonotic disease, meaning
it can be transmitted from cattle to humans. The zoonotic potential of bTB
poses a significant public health concern. Reducing zoonotic risk requires
effective disease management in cattle herds, which relies on accurate
diagnosis and timely interventions.
Key Market Trends
Advancements in Molecular Diagnostics
Molecular diagnostic techniques, such as Polymerase
Chain Reaction (PCR) and next-generation sequencing (NGS), are gaining
prominence in bTB diagnosis. These techniques offer higher sensitivity and
specificity, allowing for early and accurate detection of Mycobacterium bovis,
the causative agent of bTB. The adoption of molecular methods is expected to
increase as they become more accessible and affordable.
Point-of-Care Testing
The development of rapid, point-of-care diagnostic
tests for bTB is a significant trend in the market. These tests provide quick
results at the farm or clinic, reducing the time and cost associated with
sample transportation and centralized laboratory testing. Point-of-care tests
can improve disease management by enabling timely interventions.
Serological Assays and Antibody Detection
Serological tests that detect specific antibodies
produced in response to bTB infection are gaining attention. These tests offer
a complementary approach to traditional diagnostic methods, such as the
tuberculin skin test and interferon-gamma assays. Advancements in serological
assays aim to improve their sensitivity and specificity.
Segmental Insights
Test Type Insights
Based on the category of Tests, the traditional
testing methods had a dominant market presence and contributed significantly to
revenue in 2022. Among these traditional tests, the Single Intradermal
Comparative Cervical Tuberculin (SICCT) test stands out as the most widely used
clinical examination technique worldwide for detecting bovine TB in different
types of herds and cattle. The Agriculture and Horticulture Development Board
in the UK even recommends SICCT as the primary screening test for TB in cattle.
This test involves injecting two types of tuberculin (bovine and avian) into
the neck skin layers of animals, with the results being read 72 hours after the
injection. The test's specificity and sensitivity at a standard interpretation
are exceptionally high at 99.98%, factors that instill trust and drive product
usage, thereby enhancing the growth of this market segment.
On the other hand, the molecular diagnostic tests
segment is expected to experience a CAGR in the bovine TB diagnosis market
during the forecast period. This growth is attributed to increased research and
development efforts by key industry players aimed at developing more advanced
and reliable molecular diagnostic products. These innovations include the
adoption of rapid and precise diagnostic tools like real-time PCR for
confirming bovine TB. For instance, in February 2020, Idvet introduced the ID
Gene Mycobacterium tuberculosis complex Duplex qPCR (product code IDTUB-50 and
IDTUB-100). This test kit comes with pre-prepared reagents, a positive control,
and an external internal control. It can be used to analyze lymph nodes and
peripheral tissue samples from cattle and various other livestock animals.
Download Free Sample Report
Regional Insights
In the bovine tuberculosis (TB) diagnosis market,
Europe took the lead and captured a significant share of revenue in 2022. The
strong European presence can be attributed to several factors, including the
presence of major industry players, the implementation of strategic initiatives
aimed at expanding market reach, government programs dedicated to eradicating
bovine TB, and a substantial cattle population. As per data from the European
Commission, the cattle population in the region exceeded 77 million as of
December 2019. Additionally, another significant driving force behind regional
growth is the relatively high prevalence of bovine tuberculosis in cattle
herds. According to the European Union Reference Laboratory, the disease's
prevalence in Europe increased from 1.0% to 1.8% between 2010 and 2019.
In the Asia Pacific region, the market is poised
for rapid growth, with a projected CAGR in the coming years. This growth can be
attributed to increasing awareness about the disease in developing nations and
the rising disposable income in key markets. The increasing demand for timely
and accurate diagnosis of bovine TB, particularly in countries like India, is
further fueling market expansion. According to a study published in the
Research Gate Journal in 2018, the estimated prevalence of bovine tuberculosis
in India ranged from 14.31% to 34.42%.
Recent Developments
- In June 2020, the OIE (World Organisation for
Animal Health) hosted the seventh International Conference on Mycobacterium
bovis in Ireland. This conference had the primary goal of raising awareness and
fostering collaboration among global industry stakeholders and key players to
control and eliminate M. bovis. These proactive efforts by organizations and
companies are driving opportunities for market expansion.
Key Market Players
- IDEXX Laboratories Inc
- PBD
Biotech Ltd
- Zoetis
Inc
- Innovative
Diagnostics
- Thermo
Fisher Scientific Inc
- Enfer
Group
- AsureQuality
Australia Pty Ltd
- Bio-Rad
Laboratories Inc
- BioNote
Inc
|
By Tests
|
By Region
|
- Molecular
Diagnostic Tests
- Serological
Tests
- Traditional
Tests
|
- North
America
- Europe
- Asia-Pacific
- South
America
- Middle East
& Africa
|
Report Scope:
In this report, the Global Bovine Tuberculosis
Diagnosis Market has been segmented into the following categories, in addition
to the industry trends which have also been detailed below:
- Bovine Tuberculosis Diagnosis Market, By Tests:
o Molecular Diagnostic Tests
o Serological Tests
o Traditional Tests
- Bovine Tuberculosis Diagnosis Market, By
Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bovine
Tuberculosis Diagnosis Market.
Available Customizations:
Global Bovine Tuberculosis Diagnosis market report
with the given market data, Tech Sci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Bovine
Tuberculosis Diagnosis Market is an upcoming report to be released soon. If you
wish an early delivery of this report or want to confirm the date of release,
please contact us at [email protected]